Kindler and his wife, Sharon Sullivan, who works in the performing arts, have listed a four-bedroom, four-bath condo on West ...

They are two of the biggest rivals in the world of pharma. But the CEO of drug giant Pfizer has sprung to Moderna's defense following the Trump administration's decision to cut its funding for ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Results from the Phase III VERITAC-2 trial demonstrated that vepdegestrant reduced the risk of disease progression or death ...

For more than a decade, this is usually the time period when companies tout the steps they’re taking to lower carbon ...

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a bispecific antibody newly licensed by Pfizer.

Brad Lerman "and I have been talking about what makes sense for him and for our legal team and Brad will be leaving Starbucks ...

The oncology giant will pay $1.5 billion to co-develop a BioNTech drug that targets the proteins PD-L1 and VEGF, following ...

A Connecticut doctor who is an expert in his field said it is “one of the silent diseases that does not get the respect it ...

BMS will co-develop and co-commercialize BioNTech’s bispecific antibody BNT327 for solid tumors in a deal worth up to $11.1B ...

Bristol Myers Squibb just agreed to shower BioNTech with cash. BioNTech ( BNTX 20.01%), one of the companies made famous for ...